Document is current

Article History

Received: 2 August 2024

Accepted: 18 November 2024

First Online: 25 November 2024

Declarations

:

: The trial protocol has been approved by the Biomedical Research Ethics Committee of West China Hospital of Sichuan University (approval number: 2022–1709). The study will be conducted in accordance with the Declaration of Helsinki (as revised in 2013). Informed consent will be obtained from all the participants. Any major modifications to the trial protocol, including changes in eligibility criteria, outcome indicators, or analysis methods, will be determined by a working meeting organised by the TSC and promptly notified to all relevant parties, including the ethics committee and research sponsors. The updated version number and date on the clinical trial platform will also be used to track the history of these changes.

: Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.

: The authors declare that they have no competing interests.